Merck & Company Inc annual earnings per share (EPS) for fiscal TTM was $3.55, a decrease of 51.2% from $7.28 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $3.55 | $7.28 | $6.74 | $0.14 | $5.71 | $5.14 | $2.78 | $3.82 | $2.32 | $0.87 | $1.41 | $1.56 | $4.07 | $1.47 | $2.01 | $2.03 | $0.28 | $5.67 | $3.64 | $1.49 | $2.03 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $-1.72 | $1.19 | $2.32 | $1.76 | $2.01 | $1.47 | $1.24 | $2.14 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More MRK metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All MRK financial statements → Interactive MRK charts →
About TickerBase · Data methodology & sources